February 28, 2019
Ono Pharmaceutical said on February 27 that it has filed a new drug application in Japan for its Parkinson’s disease treatment opicapone, a catechol-O-methyltransferase (COMT) inhibitor. The drug was filed for use as adjunctive therapy to levodopa for the improvement...read more